For this episode of the Survival Medicine podcast, they talk about antivirals.
RELATED: 13 Home Remedies That Actually Work
Survival Medicine Podcast: Antivirals
Although science has made great progress against the bacterial disease, our advances against viruses are still in their infancy. Now, the potentially good news is being reported in the battle against the current pandemic: An experimental oral drug known as molnupiravir reduces the risk of hospitalization and death in phase III clinical trials.
Today Joe Alton MD (aka Dr.Bones) and Nurse Practitioner Amy Alton are going to talk about two products developed by Merck Pharmaceuticals: Ivermectin and Molnupiravir, and the evidence for their effectiveness in the COVID pandemic. Plus, why is Merck pushing this new drug over ivermectin, already FDA approved for certain parasitic issues?
All this and more on the latest episode of the Survival Medicine Podcast with Joe and Amy Alton!